Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta-analysis.
Chelsea R StoneAlexis T MickleDevon J BoyneAliya MohamedDoreen M RabiDarren R BrennerChristine M FriedenreichPublished in: Health science reports (2019)
Given the suggested increased risks of cardiovascular outcomes in lymphoma survivor populations relative to the general population, tailored screening and prevention programmes may be warranted to offset the future burden of disease.